M LH1 (Hydrochlorothiazide and lisinopril 12.5 mg / 10 mg)
Pill imprint M LH1 has been identified as Hydrochlorothiazide and lisinopril 12.5 mg / 10 mg.
Hydrochlorothiazide/lisinopril is used in the treatment of high blood pressure; heart failure and belongs to the drug class ACE inhibitors with thiazides. There is positive evidence of human fetal risk during pregnancy. Hydrochlorothiazide/lisinopril 12.5 mg / 10 mg is not a controlled substance under the Controlled Substance Act (CSA).
- M LH1
- 12.5 mg / 10 mg
- 9.00 mm
- Prescription only
- Drug Class:
- ACE inhibitors with thiazides
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- Not a controlled drug
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC):
- Inactive Ingredients:
- silicon dioxide
calcium phosphate dihydrate dibasic
sodium lauryl sulfate
|NDC Code||Manufacturer / Repackager|
|51079-0697||UDL Laboratories Inc|
Note: Inactive ingredients may vary.
More about hydrochlorothiazide/lisinopril
- Hydrochlorothiazide and lisinopril
- Lisinopril and hydrochlorothiazide (Advanced Reading)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.